Novo Nordisk, the manufacturer of Ozempic (semaglutide approved for diabetes) and Wegovy (semaglutide approved for obesity and other indications) has set a list price of $675 for each of these effective January 1, 2027
For many patients with binge-eating patterns, semaglutide itself reduces the urge to overeat by resetting appetite signals in the brain
Redox outside the box: linking extracellular redox remodeling with intracellular redox metabolism
Hair testing identifies patterns of chronic heavy drinking rather than single drinking episodes
The selection is broad 200+ weekly options from 100+ chefs and the filter surfaces meals with macro profiles appropriate for GLP-1 users
At BlueWater Wellness Center in Ponte Vedra Beach, we work with active individuals and athletes throughout the Jacksonville area who want to optimize recovery, heal injuries faster, and perform at their best